Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve 1. To consider and approve Un-Audited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter ended June 30, 2024; 2. Any other business with the permission of a Chairman.